We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About Mon suivi OMD

For optimal monitoring of your diabetic macular edema.

The My OMD Monitoring application allows you to bring together in a single tool all the important information necessary for optimal monitoring of your diabetic macular edema.

Intuitive and easy to use on a daily basis, find in the blink of an eye:

- Your medical information (constant)

- Your appointments with your healthcare professionals

- Information on the disease and its treatments.

Because being an active participant in your illness allows you to take action and limit the worsening of visual problems (1), the AbbVie laboratory has developed the “My MDG Monitoring” application for you. Talk to your doctor!

The information contained in this application is solely intended to support patients in better monitoring their care and in no way replaces the medical advice of a healthcare professional. Consult your healthcare professional with any questions regarding your treatment or your state of health.

1: SFD, SFO. Reference for the screening and monitoring of ocular complications in diabetic patients – 2016. MmM. 2016;10(8):774-84.

What's New in the Latest Version 1.1

Last updated on Nov 15, 2023

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Mon suivi OMD Update 1.1

Requires Android

12

Available on

Get Mon suivi OMD on Google Play

Show More

Mon suivi OMD Screenshots

Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.